Actinium Pharmaceuticals, Inc. (NYSE American: ATNM), announced today that two oral and four poster presentations related to its Ac-225 or Actinium-225 based ARC's or Antibody Radiation-Conjugates...

Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today announced that management will...

ORACLE HOSPITALITY CONNECT -- Updates to Oracle Hospitality OPERA Cloud Service continue to redefine how hoteliers engage and serve guests, from the time they make their reservations through to...

AllianceRx Walgreens Prime announced results from a new study demonstrating the company's oral oncology split-fill program resulted in a high rate of patient adherence, significantly reduced...

A recent study found patients with hemophilia A experienced fewer bleeds while undergoing newer extended half-life (EHL) therapy on a prophylactic (preventive) basis. The retrospective study was...